Tag: Financing

9. November 2016

Specialty pharmaceutical company AMW takes big steps

Warngau – AMW GmbH, founded in 2008 and based in Warngau south of Munich, is a dynamically growing specialist pharmaceutical company with bright prospects. The company develops and distributes transdermal systems, i.e. active ingredients that enter the body through the skin, as well as implants loaded with highly effective active ingredients, which release their active ingredient evenly to the body for months and dissolve completely. AMW is supported by well-known investors. In a recent financing round to finance growth, investors reaffirmed their commitment to AMW and contributed a further six million euros.

6. September 2014

Successful financing round for pharmaceutical companies AMW

AMW GmbH (Arzneimittelwerk Warngau) has received follow-up funding to advance the development and marketing process for its drug delivery systems. The old investors together with BayBG Bayerische Beteiligungsgesellschaft, the UnternehmerTUM-Fonds and the IBG Beteiligungsgesellschaft are depositing a total of up to seven million euros. The funds will be used to market the existing product portfolio and to develop a new technology for the controlled supply of medicinal products. AMW GmbH produces active ingredient implants as well as transdermal systems in the high-growth areas of oncology, pain therapy and neurology.

26. February 2014

AMW GmbH announces that another round of financing has been concluded with the existing shareholders.

AMW GmbH announces that another round of financing has been concluded with the existing shareholders. The funds are used to strengthen further growth and the development of innovative products. Dr. Wilfried Fischer, managing director of AMW GmbH, thanks for the trust of the shareholders in the performance of the company.